Isabelle Racine Miousse
Concepts (265)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Methionine | 11 | 2024 | 135 | 2.690 |
Why?
| DNA Methylation | 19 | 2020 | 548 | 2.580 |
Why?
| Epigenesis, Genetic | 13 | 2018 | 374 | 1.760 |
Why?
| Radiation, Ionizing | 7 | 2019 | 100 | 1.620 |
Why?
| Protons | 4 | 2023 | 69 | 1.270 |
Why?
| Infant Formula | 2 | 2022 | 145 | 1.140 |
Why?
| Animals | 38 | 2024 | 13187 | 1.020 |
Why?
| DNA Damage | 7 | 2021 | 301 | 1.010 |
Why?
| Melanoma | 4 | 2024 | 285 | 0.960 |
Why?
| Vitamin B 12 | 4 | 2012 | 27 | 0.910 |
Why?
| Mammary Glands, Animal | 2 | 2013 | 69 | 0.880 |
Why?
| Heart | 4 | 2023 | 326 | 0.860 |
Why?
| Chromosome Aberrations | 3 | 2021 | 297 | 0.810 |
Why?
| Estradiol | 2 | 2013 | 225 | 0.810 |
Why?
| Vitamin E | 2 | 2022 | 81 | 0.800 |
Why?
| Estrogens | 2 | 2013 | 227 | 0.790 |
Why?
| Mice | 22 | 2023 | 5739 | 0.780 |
Why?
| Isoflavones | 1 | 2022 | 89 | 0.770 |
Why?
| Particulate Matter | 3 | 2016 | 52 | 0.770 |
Why?
| Acute Radiation Syndrome | 2 | 2022 | 12 | 0.770 |
Why?
| Vitamin B 12 Deficiency | 3 | 2011 | 8 | 0.760 |
Why?
| Long Interspersed Nucleotide Elements | 4 | 2017 | 38 | 0.750 |
Why?
| Hematopoietic Stem Cells | 3 | 2022 | 184 | 0.750 |
Why?
| Dietary Supplements | 3 | 2020 | 443 | 0.740 |
Why?
| Nanoparticles | 3 | 2015 | 145 | 0.680 |
Why?
| Radiation Injuries, Experimental | 3 | 2020 | 81 | 0.620 |
Why?
| Bacteria | 2 | 2020 | 224 | 0.600 |
Why?
| Nucleocytoplasmic Transport Proteins | 4 | 2012 | 4 | 0.590 |
Why?
| Macrophages | 5 | 2021 | 363 | 0.590 |
Why?
| Cosmic Radiation | 2 | 2023 | 31 | 0.560 |
Why?
| Mice, Inbred C57BL | 12 | 2020 | 1816 | 0.560 |
Why?
| Radiation Injuries | 2 | 2019 | 113 | 0.550 |
Why?
| Membrane Transport Proteins | 3 | 2009 | 49 | 0.540 |
Why?
| Male | 25 | 2023 | 25241 | 0.520 |
Why?
| Chromans | 2 | 2022 | 37 | 0.510 |
Why?
| Methylmalonic Acid | 3 | 2011 | 7 | 0.510 |
Why?
| Dose-Response Relationship, Radiation | 7 | 2023 | 184 | 0.500 |
Why?
| Diet | 3 | 2021 | 566 | 0.500 |
Why?
| 5-Methylcytosine | 2 | 2022 | 16 | 0.490 |
Why?
| Trace Elements | 1 | 2014 | 9 | 0.490 |
Why?
| Metabolism, Inborn Errors | 2 | 2012 | 17 | 0.490 |
Why?
| Serum | 1 | 2014 | 32 | 0.480 |
Why?
| Zinc | 1 | 2014 | 53 | 0.470 |
Why?
| Lung | 5 | 2016 | 486 | 0.460 |
Why?
| Liver | 7 | 2022 | 1115 | 0.450 |
Why?
| Repetitive Sequences, Nucleic Acid | 5 | 2019 | 96 | 0.450 |
Why?
| Homeostasis | 1 | 2014 | 200 | 0.440 |
Why?
| Milk, Human | 1 | 2014 | 109 | 0.440 |
Why?
| Space Flight | 3 | 2019 | 34 | 0.440 |
Why?
| Hyperhomocysteinemia | 2 | 2011 | 29 | 0.420 |
Why?
| Soybean Proteins | 1 | 2013 | 161 | 0.400 |
Why?
| Protein Isoforms | 2 | 2012 | 119 | 0.390 |
Why?
| Radiation-Protective Agents | 1 | 2022 | 74 | 0.390 |
Why?
| Environmental Exposure | 3 | 2016 | 199 | 0.390 |
Why?
| Tandem Mass Spectrometry | 1 | 2022 | 236 | 0.380 |
Why?
| Activating Transcription Factor 4 | 1 | 2021 | 5 | 0.380 |
Why?
| Cysteine | 1 | 2021 | 50 | 0.380 |
Why?
| DNA Transposable Elements | 3 | 2015 | 107 | 0.380 |
Why?
| NF-E2-Related Factor 2 | 1 | 2021 | 41 | 0.370 |
Why?
| Carbon | 2 | 2019 | 54 | 0.370 |
Why?
| Gene Expression Profiling | 5 | 2018 | 1032 | 0.360 |
Why?
| Oxygen | 2 | 2023 | 326 | 0.360 |
Why?
| Bone Marrow Cells | 1 | 2021 | 191 | 0.360 |
Why?
| Neoplasms | 4 | 2018 | 1235 | 0.350 |
Why?
| Disease Models, Animal | 3 | 2022 | 1455 | 0.350 |
Why?
| Radiation Dosage | 4 | 2020 | 157 | 0.350 |
Why?
| Malnutrition | 1 | 2021 | 87 | 0.340 |
Why?
| Myocardium | 2 | 2019 | 436 | 0.340 |
Why?
| Transcobalamins | 1 | 2009 | 8 | 0.330 |
Why?
| Intestine, Small | 1 | 2020 | 109 | 0.330 |
Why?
| Cobamides | 1 | 2008 | 1 | 0.330 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 19 | 0.330 |
Why?
| Oxygen Radioisotopes | 1 | 2019 | 14 | 0.330 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2008 | 14 | 0.330 |
Why?
| Tea | 1 | 2019 | 30 | 0.330 |
Why?
| Dose-Response Relationship, Drug | 7 | 2019 | 1376 | 0.320 |
Why?
| Copper | 2 | 2015 | 43 | 0.320 |
Why?
| Methionine Adenosyltransferase | 1 | 2018 | 19 | 0.320 |
Why?
| Sex Characteristics | 1 | 2020 | 190 | 0.320 |
Why?
| DNA | 2 | 2022 | 541 | 0.310 |
Why?
| Neoplasms, Radiation-Induced | 2 | 2016 | 38 | 0.310 |
Why?
| Swine | 2 | 2022 | 393 | 0.290 |
Why?
| Humans | 26 | 2023 | 49974 | 0.290 |
Why?
| Heavy Ions | 3 | 2015 | 15 | 0.280 |
Why?
| MicroRNAs | 2 | 2017 | 353 | 0.280 |
Why?
| Radioactive Hazard Release | 1 | 2016 | 14 | 0.280 |
Why?
| Cell Transformation, Neoplastic | 1 | 2018 | 177 | 0.280 |
Why?
| Plant Extracts | 1 | 2019 | 190 | 0.280 |
Why?
| Cell Culture Techniques | 1 | 2016 | 99 | 0.270 |
Why?
| Proteins | 1 | 2009 | 342 | 0.260 |
Why?
| Radiotherapy | 1 | 2016 | 128 | 0.260 |
Why?
| Mice, Inbred CBA | 3 | 2021 | 35 | 0.260 |
Why?
| Cytotoxins | 1 | 2015 | 16 | 0.260 |
Why?
| Macrophages, Alveolar | 1 | 2015 | 28 | 0.260 |
Why?
| Radiography | 1 | 2016 | 489 | 0.260 |
Why?
| Carcinogens, Environmental | 2 | 2015 | 22 | 0.260 |
Why?
| Chemokines | 1 | 2015 | 77 | 0.250 |
Why?
| DNA, Neoplasm | 1 | 2015 | 147 | 0.250 |
Why?
| Iron | 3 | 2015 | 122 | 0.250 |
Why?
| Reactive Oxygen Species | 2 | 2015 | 408 | 0.250 |
Why?
| Gene Expression | 5 | 2019 | 609 | 0.240 |
Why?
| Environmental Pollutants | 1 | 2015 | 91 | 0.230 |
Why?
| Rats | 4 | 2023 | 3305 | 0.230 |
Why?
| Obesity | 2 | 2019 | 1113 | 0.220 |
Why?
| Oxidative Stress | 2 | 2015 | 770 | 0.210 |
Why?
| Macaca mulatta | 2 | 2022 | 93 | 0.210 |
Why?
| Genistein | 1 | 2022 | 47 | 0.200 |
Why?
| Homocysteine | 2 | 2024 | 128 | 0.200 |
Why?
| Toxicity Tests | 2 | 2017 | 52 | 0.200 |
Why?
| Reproduction | 1 | 2022 | 61 | 0.200 |
Why?
| Neoplasm Metastasis | 2 | 2018 | 231 | 0.200 |
Why?
| Ions | 2 | 2023 | 33 | 0.190 |
Why?
| Milk | 1 | 2022 | 85 | 0.190 |
Why?
| Sex Factors | 2 | 2013 | 691 | 0.190 |
Why?
| Mitochondrial Membrane Transport Proteins | 2 | 2012 | 18 | 0.190 |
Why?
| Female | 9 | 2020 | 26472 | 0.180 |
Why?
| Whole-Body Irradiation | 2 | 2022 | 131 | 0.180 |
Why?
| Apoptosis | 4 | 2021 | 1101 | 0.180 |
Why?
| Cell Line | 4 | 2015 | 1000 | 0.180 |
Why?
| Antineoplastic Agents | 1 | 2018 | 1171 | 0.180 |
Why?
| Methylation | 2 | 2022 | 122 | 0.180 |
Why?
| Inflammation | 1 | 2014 | 604 | 0.170 |
Why?
| Epithelial Cells | 3 | 2015 | 209 | 0.170 |
Why?
| Rats, Sprague-Dawley | 2 | 2013 | 1597 | 0.170 |
Why?
| Linear Energy Transfer | 2 | 2015 | 14 | 0.170 |
Why?
| Epigenomics | 3 | 2017 | 67 | 0.160 |
Why?
| Histones | 3 | 2018 | 312 | 0.160 |
Why?
| Cell Proliferation | 2 | 2021 | 1007 | 0.150 |
Why?
| Mutation | 4 | 2018 | 1294 | 0.150 |
Why?
| DNA Repair | 2 | 2021 | 193 | 0.150 |
Why?
| DNA, Satellite | 2 | 2019 | 11 | 0.150 |
Why?
| Escherichia coli | 2 | 2012 | 186 | 0.150 |
Why?
| Clofibrate | 1 | 2017 | 7 | 0.150 |
Why?
| Phenobarbital | 1 | 2017 | 17 | 0.150 |
Why?
| Periplasmic Binding Proteins | 1 | 2006 | 2 | 0.140 |
Why?
| Energy Metabolism | 2 | 2020 | 282 | 0.140 |
Why?
| Escherichia coli Proteins | 1 | 2006 | 56 | 0.130 |
Why?
| Solar Activity | 1 | 2015 | 7 | 0.130 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2017 | 195 | 0.130 |
Why?
| Risk Assessment | 3 | 2019 | 1259 | 0.130 |
Why?
| Gene Expression Regulation | 2 | 2017 | 976 | 0.130 |
Why?
| Gamma Rays | 1 | 2015 | 49 | 0.130 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1403 | 0.130 |
Why?
| Hazardous Substances | 1 | 2015 | 15 | 0.130 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 828 | 0.130 |
Why?
| Cells, Cultured | 3 | 2014 | 1573 | 0.130 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 267 | 0.120 |
Why?
| Membrane Proteins | 1 | 2006 | 341 | 0.120 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 63 | 0.120 |
Why?
| Weaning | 1 | 2013 | 29 | 0.110 |
Why?
| Genetic Association Studies | 2 | 2012 | 117 | 0.110 |
Why?
| Animals, Newborn | 1 | 2014 | 367 | 0.110 |
Why?
| Estrogen Receptor beta | 1 | 2013 | 54 | 0.110 |
Why?
| Estrogen Receptor alpha | 1 | 2013 | 89 | 0.110 |
Why?
| Receptors, Estrogen | 1 | 2013 | 130 | 0.110 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2012 | 34 | 0.110 |
Why?
| Rabbits | 1 | 2023 | 370 | 0.100 |
Why?
| Down-Regulation | 1 | 2013 | 348 | 0.100 |
Why?
| Ki-67 Antigen | 1 | 2022 | 57 | 0.100 |
Why?
| Proteome | 1 | 2024 | 173 | 0.100 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 142 | 0.100 |
Why?
| Chromatography, Liquid | 1 | 2022 | 232 | 0.100 |
Why?
| Frameshift Mutation | 1 | 2011 | 17 | 0.100 |
Why?
| Promoter Regions, Genetic | 1 | 2013 | 475 | 0.100 |
Why?
| Heterozygote | 1 | 2011 | 81 | 0.090 |
Why?
| Intestines | 1 | 2022 | 176 | 0.090 |
Why?
| Sequence Deletion | 1 | 2011 | 66 | 0.090 |
Why?
| Abnormalities, Multiple | 1 | 2012 | 167 | 0.090 |
Why?
| Lipid Peroxidation | 1 | 2021 | 100 | 0.090 |
Why?
| Chemotherapy, Adjuvant | 1 | 2021 | 119 | 0.090 |
Why?
| Exons | 1 | 2011 | 95 | 0.090 |
Why?
| Fibroblasts | 2 | 2012 | 345 | 0.090 |
Why?
| Carrier Proteins | 1 | 2012 | 304 | 0.090 |
Why?
| Cell Differentiation | 1 | 2013 | 651 | 0.090 |
Why?
| Monocytes | 1 | 2021 | 131 | 0.090 |
Why?
| Genetic Testing | 1 | 2011 | 119 | 0.090 |
Why?
| Phenotype | 2 | 2011 | 729 | 0.090 |
Why?
| Centromere | 1 | 2019 | 11 | 0.090 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2009 | 15 | 0.080 |
Why?
| Homocystinuria | 1 | 2008 | 7 | 0.080 |
Why?
| Tight Junctions | 1 | 2019 | 24 | 0.080 |
Why?
| Thinness | 1 | 2019 | 46 | 0.080 |
Why?
| Metabolic Networks and Pathways | 1 | 2019 | 89 | 0.080 |
Why?
| Tissue Distribution | 1 | 2009 | 163 | 0.080 |
Why?
| Transcriptome | 1 | 2021 | 315 | 0.080 |
Why?
| Family Health | 1 | 2008 | 80 | 0.080 |
Why?
| Chromosome Mapping | 1 | 2009 | 156 | 0.080 |
Why?
| Mitochondrial Proteins | 1 | 2008 | 90 | 0.080 |
Why?
| Infant, Newborn | 3 | 2012 | 2772 | 0.080 |
Why?
| HeLa Cells | 1 | 2009 | 250 | 0.080 |
Why?
| Polymorphism, Genetic | 1 | 2009 | 181 | 0.080 |
Why?
| Chromosome Deletion | 1 | 2009 | 140 | 0.080 |
Why?
| Animals, Outbred Strains | 1 | 2017 | 11 | 0.080 |
Why?
| Retroelements | 1 | 2017 | 14 | 0.070 |
Why?
| Administration, Oral | 1 | 2018 | 426 | 0.070 |
Why?
| Mice, Inbred Strains | 1 | 2017 | 161 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 349 | 0.070 |
Why?
| Hematopoiesis | 1 | 2017 | 71 | 0.070 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 144 | 0.070 |
Why?
| Species Specificity | 1 | 2017 | 192 | 0.070 |
Why?
| Survival Analysis | 1 | 2019 | 653 | 0.070 |
Why?
| Organ Size | 1 | 2017 | 226 | 0.070 |
Why?
| Metaphase | 1 | 2016 | 44 | 0.070 |
Why?
| Body Burden | 1 | 2016 | 11 | 0.070 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 119 | 0.070 |
Why?
| Feeding Behavior | 1 | 2018 | 181 | 0.070 |
Why?
| Models, Genetic | 1 | 2017 | 170 | 0.070 |
Why?
| Radiation Protection | 1 | 2016 | 47 | 0.070 |
Why?
| Blood Glucose | 1 | 2019 | 439 | 0.070 |
Why?
| Printing | 1 | 2015 | 4 | 0.060 |
Why?
| Welding | 1 | 2015 | 3 | 0.060 |
Why?
| Echocardiography | 1 | 2018 | 378 | 0.060 |
Why?
| Steel | 1 | 2015 | 5 | 0.060 |
Why?
| Child | 2 | 2016 | 6847 | 0.060 |
Why?
| Inhalation Exposure | 1 | 2015 | 32 | 0.060 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 237 | 0.060 |
Why?
| Titanium | 1 | 2015 | 48 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2015 | 304 | 0.060 |
Why?
| Infant | 1 | 2023 | 3567 | 0.060 |
Why?
| Time Factors | 2 | 2015 | 2903 | 0.060 |
Why?
| Lymphocytes | 1 | 2015 | 152 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 181 | 0.060 |
Why?
| L-Lactate Dehydrogenase | 1 | 2014 | 65 | 0.060 |
Why?
| In Situ Nick-End Labeling | 1 | 2014 | 57 | 0.060 |
Why?
| Protein Transport | 2 | 2012 | 180 | 0.060 |
Why?
| Heart Diseases | 1 | 2016 | 206 | 0.060 |
Why?
| Models, Molecular | 2 | 2012 | 338 | 0.060 |
Why?
| Amino Acid Sequence | 2 | 2012 | 585 | 0.060 |
Why?
| Cell Survival | 1 | 2015 | 600 | 0.060 |
Why?
| Flow Cytometry | 1 | 2015 | 476 | 0.050 |
Why?
| Protein Binding | 2 | 2012 | 660 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.050 |
Why?
| Cytokines | 1 | 2015 | 612 | 0.050 |
Why?
| Risk Factors | 1 | 2020 | 3613 | 0.050 |
Why?
| Rats, Inbred F344 | 1 | 2017 | 196 | 0.040 |
Why?
| Peptide Library | 1 | 2006 | 16 | 0.040 |
Why?
| Azacitidine | 1 | 2016 | 34 | 0.030 |
Why?
| Protein Conformation | 1 | 2006 | 166 | 0.030 |
Why?
| Interleukin-13 | 1 | 2015 | 15 | 0.030 |
Why?
| Endpoint Determination | 1 | 2015 | 24 | 0.030 |
Why?
| Genetic Markers | 1 | 2015 | 102 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2015 | 65 | 0.030 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2015 | 47 | 0.030 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2006 | 191 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 138 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 78 | 0.030 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 18 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 171 | 0.030 |
Why?
| Lung Injury | 1 | 2014 | 25 | 0.030 |
Why?
| Genes, Recessive | 1 | 2012 | 16 | 0.030 |
Why?
| Cell Surface Display Techniques | 1 | 2012 | 1 | 0.030 |
Why?
| Native Polyacrylamide Gel Electrophoresis | 1 | 2012 | 1 | 0.030 |
Why?
| Protein Structure, Secondary | 1 | 2012 | 72 | 0.030 |
Why?
| Oxidoreductases | 1 | 2012 | 60 | 0.030 |
Why?
| Disease Progression | 1 | 2015 | 825 | 0.030 |
Why?
| Circular Dichroism | 1 | 2012 | 41 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2012 | 175 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2012 | 253 | 0.030 |
Why?
| Binding Sites | 1 | 2012 | 374 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2012 | 486 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2012 | 792 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 1131 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2014 | 606 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2011 | 2182 | 0.020 |
Why?
| Adolescent | 1 | 2011 | 6356 | 0.010 |
Why?
|
|
Racine Miousse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|